why choose us

First received: March 28, 2024

Clinical Trial: A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Malignant Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Phase I Study to Evaluate the Safety, Tolerance and Pharmacokinetics of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Brief Summary: This study includes two stage: dose escalation and dose extension, with a single dose and a multiple dose study.This is a single-center, open, non-randomized, single arm, study to evaluate the safety, tolerability and pharmacokinetics of TQB3006 tables in patients with advanced malignant cancer.

Read more